Moderate or severe OHSS · women undergoing assisted reproduction
Dopamine agonist probably leads to lower incidence of moderate or severe OHSS compared with placebo/no intervention (moderate certainty).
1 finding from 1 review
Moderate or severe OHSS · women undergoing assisted reproduction
It is very uncertain whether dopamine agonist changes incidence of moderate or severe OHSS compared with other active intervention (very low certainty).
1 finding from 1 review
Live birth rate · women undergoing assisted reproduction
Dopamine agonist showed no clear difference in live birth rate compared with other active intervention (low certainty).
1 finding from 1 review
Clinical pregnancy rate · women undergoing assisted reproduction
Dopamine agonist showed no clear difference in clinical pregnancy rate compared with other active intervention (moderate certainty).
1 finding from 1 review
Multiple pregnancy rate · women undergoing assisted reproduction
Dopamine agonist showed no clear difference in multiple pregnancy rate compared with other active intervention (low certainty).
1 finding from 1 review
Miscarriage · women undergoing assisted reproduction
Dopamine agonist showed no clear difference in miscarriage rate compared with other active intervention (low certainty).
1 finding from 1 review
Any other adverse events · women undergoing assisted reproduction
1 finding from 1 review
Live birth rate · women undergoing assisted reproduction
Dopamine agonist showed no clear difference in live birth rate compared with placebo/no intervention (low certainty).
1 finding from 1 review
Clinical pregnancy rate · women undergoing assisted reproduction
Dopamine agonist showed no clear difference in clinical pregnancy rate compared with placebo/no intervention (low certainty).
1 finding from 1 review
Multiple pregnancy rate · women undergoing assisted reproduction
It is very uncertain whether dopamine agonist changes multiple pregnancy rate compared with placebo/no intervention (very low certainty).
1 finding from 1 review
Miscarriage · women undergoing assisted reproduction
Dopamine agonist showed no clear difference in miscarriage rate compared with placebo/no intervention (low certainty).
1 finding from 1 review
Any other adverse events · women undergoing assisted reproduction
It is very uncertain whether dopamine agonist changes any other adverse events compared with placebo/no intervention (very low certainty).
1 finding from 1 review
Multiple pregnancy rate · women undergoing assisted reproduction
It is very uncertain whether dopamine agonist plus co‐intervention changes multiple pregnancy rate compared with co‐intervention (very low certainty).
1 finding from 1 review
Miscarriage · women undergoing assisted reproduction
Dopamine agonist plus co‐intervention showed no clear difference in miscarriage rate compared with co‐intervention (low certainty).
1 finding from 1 review
Any other adverse events · women undergoing assisted reproduction
It is very uncertain whether dopamine agonist plus co‐intervention changes any other adverse events compared with co‐intervention (very low certainty).
1 finding from 1 review
Moderate or severe OHSS · women undergoing assisted reproduction
Dopamine agonist plus co‐intervention may leads to lower incidence of moderate or severe OHSS compared with co‐intervention (low certainty).
1 finding from 1 review
Live birth rate · women undergoing assisted reproduction
Dopamine agonist plus co‐intervention showed no clear difference in live birth rate compared with co‐intervention (low certainty).
1 finding from 1 review
Clinical pregnancy rate · women undergoing assisted reproduction
Dopamine agonist plus co‐intervention showed no clear difference in clinical pregnancy rate compared with co‐intervention (low certainty).
1 finding from 1 review